Novartis has recently reached a settlement with the estate of Henrietta Lacks, putting an end to a lawsuit that accused the pharmaceutical company of profiting off her cells without her knowledge. The cells, taken from Lacks’ tumor in 1951, were used in labs for various medical advancements, including the development of the polio vaccine. The details of the settlement, finalized in federal court in Maryland, have not been disclosed to the public.
In a joint statement, the Lacks family and Novartis expressed their satisfaction with resolving the matter outside of court. This settlement marks the second agreement in lawsuits filed by the estate, seeking to address the exploitation of Black patients like Lacks by biomedical companies. Lacks, a mother who passed away at the age of 31, had her cells taken without consent and went on to become a crucial component in scientific research.
The lawsuit against Novartis demanded the full amount of net profits obtained from commercializing the HeLa cell line, which was cultivated from what the complaint described as “stolen cells.” The legal battle sheds light on the broader issue of medical exploitation and the lack of compensation for individuals whose cells have contributed significantly to scientific progress.
The story of Henrietta Lacks is a poignant one. Doctors at Johns Hopkins Hospital took her cervical cells without her knowledge, leading to the creation of the first immortalized human cell line. Despite the monumental impact of HeLa cells on medical research, the Lacks family did not receive any compensation for their contributions.
In 2023, the estate reached a settlement with Thermo Fisher Scientific Inc., another company accused of profiting from Lacks’ cells. The legal battles continue, with ongoing lawsuits against companies like Ultragenyx Pharmaceutical and Viatris. Attorneys for the family have hinted at the possibility of additional complaints being filed in the future.
Henrietta Lacks, a poor tobacco farmer from Virginia, unwittingly became a central figure in medical history. Her cells, which were able to thrive and reproduce in laboratories unlike others, revolutionized the field of scientific research. Despite the immense impact of her cells, Lacks’ story sheds light on the injustices faced by marginalized communities in the medical industry.
The legacy of Henrietta Lacks lives on through the bestselling book “The Immortal Life of Henrietta Lacks” by Rebecca Skloot, which brought her story to a wider audience. The impact of her cells on medical science cannot be overstated, and the settlement with Novartis represents a step towards acknowledging and rectifying past wrongs.
